semaglutide vs tirzepatide are FDA-approved injectable medications proven to produce significant weight loss when combined with diet and lifestyle changes
The right option depends on individual health history, provider review, medication suitability, preferences, and clinical appropriateness
By activating GIP and GLP-1 receptors, tirzepatide enhances insulin secretion when blood glucose levels are elevated, suppresses glucagon release, slows gastric emptying, and reduces appetite through effects on brain centers that control hunger
Studies generally report a weight loss of about 15-16% of initial body weight with Semaglutide, while Tirzepatide can result in a 14-18% reduction
Click here to read the OFA lawsuit
Your provider will go through the full list and make sure everything looks safe together